Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2022
Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorderJennifer Ward, H Miles Prince, Chris McCormack, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2021
Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15Michael P MacManus, Daniel Roos, Peter O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal responseRita A Busuttil, Joshy George, Richard W Tothill, et al.
British Journal of Haematology|June 25, 2025
Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomesPhilippa Johnstone, Martin Higgins, H Miles Prince, et al.
ANZ Journal of Surgery|May 2, 2002
Rectal cancer in Victoria in 1994: patterns of reported managementK Chip Farmer, Campbell Penfold, Jeremy L Millar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2025
Radiotherapy dose-response of mycosis fungoides with large cell transformationMartin J Higgins, Philippa Johnstone, H Miles Prince, et al.
Cancer Research|May 17, 2003
Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancerAlex Boussioutas, Hong Li, Jia Liu, et al.
Blood|August 31, 2019
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndromeCrystal Gao, Christopher McCormack, Carrie van der Weyden, et al.
Internal Medicine Journal|October 20, 2021
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceGreg Hapgood, Maya Latimer, Sze Ting Lee, et al.
Blood|May 6, 2017
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclaxMary Ann Anderson, Constantine Tam, Thomas E Lew, et al.
Pageof 6